News and Press Releases

DNA analysis of Parsortix-enriched CTCs and ctDNA provides complementary information in NSCLC patients treated with AstraZeneca’s osimertinib

The addition of CTC-DNA analysis to clinical trials could identify patients developing treatment resistance prior to disease progression CTC analysis identifies druggable targets which could be used to inform combined...

Category: Biotechnology, Clinical Trials
Posted: November 11, 2024

2 Occam Court, Occam Road, Surrey Research Park, Guilford, GU2 7QB

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

Zero refusals to file and a SOUL mindset helped solidify the honor 8 November 2024 -- Michigan, US -- MMS, a leading data and regulatory focused clinical research organization (CRO),...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 8, 2024

6880 Commerce Blvd. Canton, MI 48187 USA

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma

If approved, daratumumab will become the first treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering a novel approach to treat before the onset...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: November 8, 2024

Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG

Slow uptake of centralised data processes is preventing analytic maturity in manufacturing and supply chain firms, research reveals 

Research from Alteryx finds that significant portions of the sector are missing out on more streamlined data analytics functions  5 November 2024 – London, UK – Decentralised data and processes...

Category: Logistics, Manufacturing and Packing
Posted: November 7, 2024

133 Houndsditch 04-101 London, United Kingdom EC3A 7DB

From Discovery Park to Merck, Top Industry Players to Showcase at London Biotechnology Show 2025

7 November 2024 -- London, UK -- Back for its second year, the London Biotechnology Show (#LBS25) gathers prominent biotech leaders, policymakers, and industry enthusiasts for an unparalleled showcase. Attendees...

Category: Biotechnology, Other, Pharmaceutical
Posted: November 7, 2024

Abu Dhabi to showcase expertise in genomics at American Society of Human Genetics 2024 Annual Meeting in Colorado

Representatives from the Department of Health – Abu Dhabi (DoH), M42 and Khalifa University to highlight the role of genomics in advancing and delivering transformative healthcare solutions on a population...

Category:
Posted: November 7, 2024

Building 35 Kanadel Street, Al Rawda – Abu Dhabi - Postal code 20224

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

5 November 2024 – STRASBOURG, France and BERLIN, Germany – -- Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and ProBioGen,...

Category:
Posted: November 6, 2024

Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences

6 November 2024– London, UK – Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces...

Category: Biotechnology
Posted: November 6, 2024

Quell Therapeutics Ltd, Translation & Innovation Hub, 84 Wood Lane, London, W12 OBZ

Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI

5 November 2024 –Tokyo, Japan and London and Cardiff, UK – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio...

Category: BioManufacturing
Posted: November 6, 2024

Midtown East 9-7-2 Akasaka Minato-ku Tokyo 107-0052

Bespak and Orbia Fluor & Energy Materials unite to accelerate transition to climate-friendly inhalers

Collaboration aims to speed the commercialisation of low global warming potential pMDIs utilising Orbia Fluor & Energy Materials’ Zephex® 152a propellant at Bespak’s Holmes Chapel site 6 November 2024 –...

Category: Drug Delivery, Manufacturing and Packing
Posted: November 6, 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses Our innovative decentralized cell therapy...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 5, 2024

Galapagos NV Generaal De Wittelaan L11 A3 2800 Mechelen, Belgium

Seaport Therapeutics Names Lauren White as Chief Financial Officer

November 5, 2024 – Boston, MA, US – Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team,...

Category: Biotechnology
Posted: November 5, 2024

6 Tide Street, Suite 400, Seaport Boston, MA 02210

NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink

The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies and opportunities for people to take part in research and...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 5, 2024

2nd Floor Bright Building Manchester Science Park Pencroft Way Manchester M15 6GZ

PTC Therapeutics to Participate at Upcoming Investor Conferences

4 November 2024 -- New Jersey, US -- PTC Therapeutics, Inc today announced that the company will present a company overview at the following conferences: UBS Global Healthcare ConferenceWednesday, Nov....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 4, 2024

PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449

Travere Therapeutics to Present at Upcoming Investor Conferences

4 November 2024 -- California, US -- Travere Therapeutics, Inc today announced that company management will present in the following upcoming investor conferences in November: Guggenheim Securities Healthcare Innovation ConferenceMonday, November 11,...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 4, 2024

3611 Valley Centre Drive, Suite 300 San Diego, CA 92130